Delivery Order SPE2DB24D1104-SPE2DB25FYCL1

Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a ceiling value of $28,487.26 and is a firm fixed price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a medication, with a ceiling value of $1,461.05 and a period of performance through April 17, 2025. This award is not a set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a medical product, and has a ceiling value of $5,012.55. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the drug BARHEMSYS 5 MG/2 ML VIAL 2ML. The contract has a firm fixed price of $1,621.32 and a completion date of July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product BARHEMSYS 10 MG/4 ML VIAL 4ML, with a ceiling value of $3,263.93 and a period of performance through June 11, 2025. The contract is a firm fixed-price delivery order, indicating the agency has a defined requirement and has competitively awarded the order to AmerisourceBergen. As...
This federal contract award, valued at $1,462.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of December 13, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,215.41, is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567212297 - BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $1,310.68 and has a completion date of February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,207.10 contract is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a medical product, with a period of performance through June 30, 2025. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BARHEMSYS, a medication used to treat postoperative nausea and vomiting, with a ceiling value of $21,784.03 and a performance period through April 2025. The contract is not set aside and is a firm-fixed-price delivery order, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYCL1
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, with a ceiling value of $1,872.03 and a period of performance through June 25, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/28/25, 1:52 AM